mRNA-engineered mesenchymal stromal cells expressing CXCR2 enhances cell migration and improves recovery in IBD
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mRNA-engineered mesenchymal stromal cells expressing CXCR2 enhances cell migration and improves recovery in IBD
Authors
Keywords
mesenchymal stromal cells, CXCL2, CXCL5, IBD, CXCR2, sema7A
Journal
Molecular Therapy-Nucleic Acids
Volume 26, Issue -, Pages 222-236
Publisher
Elsevier BV
Online
2021-07-22
DOI
10.1016/j.omtn.2021.07.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease
- (2020) Yong Fu et al. MOLECULAR THERAPY
- Semaphorin‐3E attenuates intestinal inflammation through the regulation of the communication between splenic CD11C + and CD4 + CD25 − T‐cells
- (2019) Laëtitia Kermarrec et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas
- (2019) Marieke C Barnhoorn et al. Journal of Crohns & Colitis
- Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
- (2019) Henry Caplan et al. Frontiers in Immunology
- Semaphorin 3E regulates apoptosis in the intestinal epithelium during the development of colitis
- (2019) Nour Eissa et al. BIOCHEMICAL PHARMACOLOGY
- Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease
- (2018) Julián Panés et al. GASTROENTEROLOGY
- Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise
- (2018) Palak J Trivedi et al. Journal of Crohns & Colitis
- Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis
- (2018) Nicholas A. Scott et al. Science Translational Medicine
- Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection
- (2017) Janine Kah et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact Hypersensitivity
- (2017) Xiaoran Zhang et al. MOLECULAR THERAPY
- Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation
- (2017) C. Manferdini et al. OSTEOARTHRITIS AND CARTILAGE
- Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells againstToxoplasma gondii
- (2017) Aiping Qin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
- (2017) Yun Qiu et al. Stem Cell Research & Therapy
- The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses
- (2016) T. Dhere et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases
- (2016) C. Grégoire et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
- (2016) Julián Panés et al. LANCET
- Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine
- (2015) Emanuela Sala et al. GASTROENTEROLOGY
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
- (2015) Zahava Vadasz et al. PLoS One
- Macrophage-Restricted Interleukin-10 Receptor Deficiency, but Not IL-10 Deficiency, Causes Severe Spontaneous Colitis
- (2014) Ehud Zigmond et al. IMMUNITY
- Macrophages in intestinal homeostasis and inflammation
- (2014) Calum C. Bain et al. IMMUNOLOGICAL REVIEWS
- Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10
- (2014) Y Peng et al. LEUKEMIA
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation
- (2013) O. Levy et al. BLOOD
- A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy
- (2013) Geoffrey M. Forbes et al. Clinical Gastroenterology and Hepatology
- PDGFRα and CD51 mark human Nestin+sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion
- (2013) Sandra Pinho et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors
- (2013) Shuhei Watanabe et al. JOURNAL OF GASTROENTEROLOGY
- Protection against colitis by CD100-dependent modulation of intraepithelial γδ T lymphocyte function
- (2013) T F Meehan et al. Mucosal Immunology
- Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula
- (2013) Woo Yong Lee et al. STEM CELLS
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- Adult Human RPE Can Be Activated into a Multipotent Stem Cell that Produces Mesenchymal Derivatives
- (2012) Enrique Salero et al. Cell Stem Cell
- Butyricicoccus pullicaecorumin inflammatory bowel disease
- (2012) Venessa Eeckhaut et al. GUT
- Intestinal Epithelial Cell-Derived Semaphorin 7A Negatively Regulates Development of Colitis via v 1 Integrin
- (2011) S. Kang et al. JOURNAL OF IMMUNOLOGY
- Targeting chemokine receptors in chronic inflammatory diseases: An extensive review
- (2011) Pim J. Koelink et al. PHARMACOLOGY & THERAPEUTICS
- Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease
- (2010) D F Godoi et al. BONE MARROW TRANSPLANTATION
- Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease
- (2010) Giacomo Lanzoni et al. CYTOTHERAPY
- Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
- (2010) Marjolijn Duijvestein et al. GUT
- Mesenchymal Stem Cell Homing: The Devil Is in the Details
- (2009) Jeffrey M. Karp et al. Cell Stem Cell
- Derivation, characterization and gene modification of cynomolgus monkey mesenchymal stem cells
- (2009) Hui Ke et al. DIFFERENTIATION
- Introducing Transcription Factors to Multipotent Mesenchymal Stem Cells: Making Transdifferentiation Possible
- (2009) Ran Barzilay et al. STEM CELLS
- Mesenchymal Stromal Cells â Current Understanding and Clinical Status
- (2009) H. K. Salem et al. STEM CELLS
- Mesenchymal Stem Cell Homing Capacity
- (2009) Valeria Sordi TRANSPLANTATION
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
- (2008) Michael D. Kappelman et al. GASTROENTEROLOGY
- Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses
- (2008) Manuel A. González et al. GASTROENTEROLOGY
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
- (2008) Krisztián Németh et al. NATURE MEDICINE
- mRNA Transfection of CXCR4-GFP Fusion—Simply Generated by PCR—Results in Efficient Migration of Primary Human Mesenchymal Stem Cells
- (2008) Martin F. Ryser et al. TISSUE ENGINEERING PART C-METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More